Cognitive Remediation for HIV-associated Neurocognitive Dysfunction
Completed · Not applicable
Conditions studied: HIV-associated Neurocognitive Dysfunction
In brief
This study is a validation study to document the acceptability of the revised Plasticity-based Adaptive Cognitive Remediation (PACR) program to patients with HIV-associated Neurocognitive Dysfunction (HAND). The primary objective of this study is to evaluate the effects of the revised PACR program on the cognitive abilities (e.g., attention, executive function), functional status and quality of life of individuals diagnosed with HAND. The secondary objective of the study is to collect relevant data to support a pre-investigational device exemption (IDE) submission to the FDA required before the pivotal randomized, controlled trial planned for Phase II.
Key facts
- Study ID
- NCT02671526
- Run by
- Posit Science Corporation
- People needed
- 19
- Starts
- 2015-12-01
- Expected to finish
- 2016-11-01
- Last updated by the study team
- 2016-11-23
Who can join
Age: 25 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Posit Science Corporation — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.